| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.037 | 0.5 |